| Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes AR Cox, JF Marriott, KA Wilson, RE Ferner Journal of clinical pharmacy and therapeutics 29 (1), 31-35, 2004 | 77 | 2004 |
| A patient’s perspective: the impact of adverse drug reactions on patients and their views on reporting S Lorimer, A Cox, NJ Langford Journal of clinical pharmacy and therapeutics 37 (2), 148-152, 2012 | 69 | 2012 |
| Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal … TF Butt, AR Cox, H Lewis, RE Ferner Drug Safety 34 (4), 319-328, 2011 | 57 | 2011 |
| Deaths from medicines: a systematic analysis of coroners’ reports to prevent future deaths RE Ferner, C Easton, AR Cox Drug Safety 41, 103-110, 2018 | 48 | 2018 |
| Identification of different side effects between PARP inhibitors and their polypharmacological multi‐target rationale D Sandhu, AA Antolin, AR Cox, AM Jones British Journal of Clinical Pharmacology 88 (2), 742-752, 2022 | 44 | 2022 |
| Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis TF Butt, AR Cox, JR Oyebode, RE Ferner Drug Safety 35 (12), 1159-1170, 2012 | 41 | 2012 |
| Adverse drug reactions in patients admitted to hospital identified by discharge ICD‐10 codes and by spontaneous reports AR Cox, C Anton, CHF Goh, M Easter, NJ Langford, RE Ferner British journal of clinical pharmacology 52 (3), 337-339, 2001 | 41 | 2001 |
| Prescribing errors in diabetes AR Cox, RE Ferner The British Journal of Diabetes & Vascular Disease 9 (2), 84-88, 2009 | 39 | 2009 |
| The safety of spironolactone treatment in patients with heart failure C Anton, AR Cox, RDS Watson, RE Ferner Journal of clinical pharmacy and therapeutics 28 (4), 285-287, 2003 | 38 | 2003 |
| Preventing future deaths from medicines: responses to coroners’ concerns in England and Wales RE Ferner, T Ahmad, Z Babatunde, AR Cox Drug Safety 42, 445-451, 2019 | 24 | 2019 |
| Communications skills in the pharmacy profession: a cross sectional survey of UK registered pharmacists and pharmacy educators Z Jalal, A Cox, N Goel, N Vaitha, K King, J Ward Pharmacy 6 (4), 132, 2018 | 23 | 2018 |
| Restoring confidence in vaccines by explaining vaccine safety monitoring: Is a targeted approach needed? RE Casiday, AR Cox Drug safety 29 (12), 1105-1109, 2006 | 21 | 2006 |
| Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters AR Cox, C Anton, SE McDowell, JF Marriott, RE Ferner British journal of clinical pharmacology 69 (5), 529-534, 2010 | 20 | 2010 |
| Adverse drug reactions: when the risk becomes a reality for patients AR Cox, TF Butt Drug Safety 35 (11), 977-981, 2012 | 19 | 2012 |
| Amateur endurance athletes' use of non‐steroidal anti‐inflammatory drugs: a cross‐sectional survey. WE Rudgard, CA Hirsch, AR Cox International Journal of Pharmacy Practice 27 (1), 2019 | 18 | 2019 |
| Pharmacokinetics and pharmacodynamics of oral P2Y12 inhibitors during the acute phase of a myocardial infarction: A systematic review N Khan, AR Cox, JM Cotton Thrombosis Research 143, 141-148, 2016 | 18 | 2016 |
| A response to the article on the association between paracetamol/acetaminophen: use and autism by Stephen T. Schultz AR Cox, S Mcdowell Autism 13 (1), 123-124, 2009 | 18 | 2009 |
| Broad Spectrum: Embracing ADR reporting could improve pharmacists' standing A Cox Pharmaceutical Journal 269, 14-14, 2002 | 18 | 2002 |
| A qualitative study of prescribing errors among multi-professional prescribers within an e-prescribing system F Alshahrani, JF Marriott, AR Cox International journal of clinical pharmacy 43 (4), 884-892, 2021 | 17 | 2021 |
| Drug-related problems in hospitalised patients with chronic kidney disease: A systematic review WS Alruqayb, MJ Price, V Paudyal, AR Cox Drug safety, 1-18, 2021 | 16 | 2021 |
John MarriottVerified email at bham.ac.uk
